Table 3.
Multivariate Cox analysis of choline and clinical outcomes in PAH subgroup
| Variable | HR | 95% CI | P |
|---|---|---|---|
| Choline * (time < 240 days) | 0.894 | 0.194–4.114 | 0.886 |
| Choline * (time ≥ 240 days) | 2.395 | 1.072–5.352 | 0.033 |
| Age, years | 0.985 | 0.959–1.012 | 0.262 |
| BMI, kg/m2 | 0.969 | 0.891–1.055 | 0.468 |
| WHO-FC | 1.516 | 0.717–3.207 | 0.277 |
| Total cholesterol, mM | 1.113 | 0.768–1.613 | 0.573 |
| Triglycerides, mM | 1.056 | 0.649–1.717 | 0.828 |
| 6MWD, m | 0.998 | 0.994–1.002 | 0.286 |
Plasma choline levels were put into the model as a categorical variable bounded by 50th percentile (12.6 µM). PAH: pulmonary arterial hypertension; BMI: body mass index; WHO FC: world health organization function class; 6MWT: 6-minute walk distance